
Biotech & Health
FDA Generative AI Policy Gains Priority
The FDA is preparing draft guidance on generative AI medical devices after receiving more than 500 submissions, with the policy work now a priority at the highest levels of the administration.
1 article

The FDA is preparing draft guidance on generative AI medical devices after receiving more than 500 submissions, with the policy work now a priority at the highest levels of the administration.
Written by the reporters who cover each beat. Unsubscribe in one click.